Search

everythinglearnresearchcommunity

for

Search:↓

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Gefitinib can cause hair and eyebrow darkening.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

BIK1 gene helps plants resist some pathogens but makes them more vulnerable to others.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

A20 protein is crucial for normal skin and hair development.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.